Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Catheter Precision (VTAK) Finished Goods (2017 - 2025)

Catheter Precision has reported Finished Goods over the past 9 years, most recently at $49000.0 for Q4 2025.

  • Quarterly Finished Goods rose 226.67% to $49000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $49000.0 through Dec 2025, up 226.67% year-over-year, with the annual reading at $49000.0 for FY2025, 226.67% up from the prior year.
  • Finished Goods was $49000.0 for Q4 2025 at Catheter Precision, up from $11000.0 in the prior quarter.
  • Over five years, Finished Goods peaked at $132000.0 in Q1 2021 and troughed at $5000.0 in Q4 2021.
  • The 5-year median for Finished Goods is $24000.0 (2025), against an average of $41727.3.
  • Year-over-year, Finished Goods tumbled 94.7% in 2022 and then skyrocketed 226.67% in 2025.
  • A 5-year view of Finished Goods shows it stood at $5000.0 in 2021, then soared by 40.0% to $7000.0 in 2022, then skyrocketed by 142.86% to $17000.0 in 2023, then fell by 11.76% to $15000.0 in 2024, then skyrocketed by 226.67% to $49000.0 in 2025.
  • Per Business Quant, the three most recent readings for VTAK's Finished Goods are $49000.0 (Q4 2025), $11000.0 (Q3 2025), and $24000.0 (Q2 2025).